Company intelligence / Profile preview

Nylos

New York, New York, United States

Ownership: Private
Employees: ~10
Development stage: Other

Overview

Nylos was a digital health and personalized nutrition company that specialized in leveraging biological data to optimize human performance. The company developed a platform that analyzed blood biomarkers and gut microbiome composition to provide users with tailored dietary and lifestyle recommendations. Primarily focused on athletes and wellness enthusiasts, Nylos aimed to bridge the gap between complex laboratory results and actionable daily habits. The startup was part of the Techstars NYC 2020 cohort and was acquired by InsideTracker in December 2021 to enhance their personalized health analytics ecosystem.

Therapeutic areas: OtherMetabolic Disorders
Modalities: Diagnostic TestDigital Health Platform
Industry: Molecular Diagnostics

Partnerships

Techstars

Beyond the preview

Go deeper on Nylos.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Nylos.

Explore the full profile